Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model

Introduction: Taiwan has several hepatitis C virus (HCV) hyper-endemic areas. We aimed to evaluate the effectiveness and safety of a collaborative HCV care system with an outreach decentralized strategy among the resource-constrained rural/remote areas of Taiwan. Methods: The pilot study was conduct...

Full description

Bibliographic Details
Main Authors: Ching-Chu Lo, Wei-Yi Lei, Ying-Che Huang, Jow-Jyh Hwang, Chen-Yu Lo, Chien-hung Lin, Hsu-sheng Cheng, Yee-Tam Liao, Po-Cheng Liang, Meng-Jau Chiou, Ming-Jong Bair, Chia-Yen Dai, Ming-Lung Yu
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118223000336
_version_ 1797749200334618624
author Ching-Chu Lo
Wei-Yi Lei
Ying-Che Huang
Jow-Jyh Hwang
Chen-Yu Lo
Chien-hung Lin
Hsu-sheng Cheng
Yee-Tam Liao
Po-Cheng Liang
Meng-Jau Chiou
Ming-Jong Bair
Chia-Yen Dai
Ming-Lung Yu
author_facet Ching-Chu Lo
Wei-Yi Lei
Ying-Che Huang
Jow-Jyh Hwang
Chen-Yu Lo
Chien-hung Lin
Hsu-sheng Cheng
Yee-Tam Liao
Po-Cheng Liang
Meng-Jau Chiou
Ming-Jong Bair
Chia-Yen Dai
Ming-Lung Yu
author_sort Ching-Chu Lo
collection DOAJ
description Introduction: Taiwan has several hepatitis C virus (HCV) hyper-endemic areas. We aimed to evaluate the effectiveness and safety of a collaborative HCV care system with an outreach decentralized strategy among the resource-constrained rural/remote areas of Taiwan. Methods: The pilot study was conducted in four high HCV-endemic townships in the rural/remote areas of Taoyuan, Alishan, Zhuoxi and Xiulin. Registered residents who worked or lived in the four areas and were aged 30–75 years were invited to participate in this program. Multidisciplinary HCV care teams provided outreach decentralized services of anti-HCV screening, link-to-diagnosis, and link-to-treatment with direct-acting antiviral agents (DAA). The primary end-point was sustained virological response (SVR). Results: Of 8291 registered residents who were invited as the target population, 7807 (94.2%) subjects received anti-HCV screening, with the average anti-HCV prevalence rate of 14.2% (1108/7807) (range among four areas: 11.8%–16.7%). The rate of link-to-diagnosis was 94.4% (1046/1108) of anti-HCV-positive subjects (range: 90.9%–100%) with an average HCV-viremic rate of 55.1% (576/1046) (range: 50.0%–64.3%). The link-to-treat rate was 94.4% (544/576) in HCV-viremic subjects (range from 92.7% to 97.2%). Overall, 523 (96.1%) patients achieved an SVR (range: 94.7%–97.6%). Eventually, the overall effectiveness was 80.7% (range: 74.6%–93.1%). The presence of hepatocellular carcinoma at baseline was the only factor associated with DAA failure. The DAA regimens were well-tolerated. Conclusion: The outreach decentralized community-based care system with DAA therapy was highly effective and safe in the achievement of HCV micro-elimination in the resource-constrained rural and remote regions, which could help us to tackle the disparity.
first_indexed 2024-03-12T16:15:51Z
format Article
id doaj.art-ccf76717e93e4e2c88dfeab2fdf7f592
institution Directory Open Access Journal
issn 1684-1182
language English
last_indexed 2024-03-12T16:15:51Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Journal of Microbiology, Immunology and Infection
spelling doaj.art-ccf76717e93e4e2c88dfeab2fdf7f5922023-08-09T04:32:14ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822023-08-01564680687Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care modelChing-Chu Lo0Wei-Yi Lei1Ying-Che Huang2Jow-Jyh Hwang3Chen-Yu Lo4Chien-hung Lin5Hsu-sheng Cheng6Yee-Tam Liao7Po-Cheng Liang8Meng-Jau Chiou9Ming-Jong Bair10Chia-Yen Dai11Ming-Lung Yu12Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, TaiwanDepartment of Medicine, Hualien Tzu Chi Hospital, Buddihist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital Yuli Branch, Taipei, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, Taiwan; Eberly College of Science, Department of Biology, Schreyer Honors College, Pennsylvania State University, United StatesDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, St. Martin De Porres Hospital, Chung-Jen Junior College of Nursing, Health Sciences and Management, Chiayi, TaiwanHepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Hepatitis Research Center, College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung, TaiwanTaoyuan District Public Health Center, Kaohsiung, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Taitung Mackay Memorial Hospital, Taitung, Taiwan; Department of Medicine, Mackay Medical College, New Taipei, Taiwan; Corresponding author. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital-Taitung Branch, Taiwan.Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Hepatitis Research Center, College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung, Taiwan; School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan; Corresponding author. Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Hepatitis Research Center, College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung, Taiwan; School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan; Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, TaiwanIntroduction: Taiwan has several hepatitis C virus (HCV) hyper-endemic areas. We aimed to evaluate the effectiveness and safety of a collaborative HCV care system with an outreach decentralized strategy among the resource-constrained rural/remote areas of Taiwan. Methods: The pilot study was conducted in four high HCV-endemic townships in the rural/remote areas of Taoyuan, Alishan, Zhuoxi and Xiulin. Registered residents who worked or lived in the four areas and were aged 30–75 years were invited to participate in this program. Multidisciplinary HCV care teams provided outreach decentralized services of anti-HCV screening, link-to-diagnosis, and link-to-treatment with direct-acting antiviral agents (DAA). The primary end-point was sustained virological response (SVR). Results: Of 8291 registered residents who were invited as the target population, 7807 (94.2%) subjects received anti-HCV screening, with the average anti-HCV prevalence rate of 14.2% (1108/7807) (range among four areas: 11.8%–16.7%). The rate of link-to-diagnosis was 94.4% (1046/1108) of anti-HCV-positive subjects (range: 90.9%–100%) with an average HCV-viremic rate of 55.1% (576/1046) (range: 50.0%–64.3%). The link-to-treat rate was 94.4% (544/576) in HCV-viremic subjects (range from 92.7% to 97.2%). Overall, 523 (96.1%) patients achieved an SVR (range: 94.7%–97.6%). Eventually, the overall effectiveness was 80.7% (range: 74.6%–93.1%). The presence of hepatocellular carcinoma at baseline was the only factor associated with DAA failure. The DAA regimens were well-tolerated. Conclusion: The outreach decentralized community-based care system with DAA therapy was highly effective and safe in the achievement of HCV micro-elimination in the resource-constrained rural and remote regions, which could help us to tackle the disparity.http://www.sciencedirect.com/science/article/pii/S1684118223000336HCVDAASVRRural area
spellingShingle Ching-Chu Lo
Wei-Yi Lei
Ying-Che Huang
Jow-Jyh Hwang
Chen-Yu Lo
Chien-hung Lin
Hsu-sheng Cheng
Yee-Tam Liao
Po-Cheng Liang
Meng-Jau Chiou
Ming-Jong Bair
Chia-Yen Dai
Ming-Lung Yu
Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
Journal of Microbiology, Immunology and Infection
HCV
DAA
SVR
Rural area
title Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
title_full Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
title_fullStr Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
title_full_unstemmed Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
title_short Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model
title_sort micro elimination of hepatitis c virus infection in the rural and remote areas of taiwan a multi center collaborative care model
topic HCV
DAA
SVR
Rural area
url http://www.sciencedirect.com/science/article/pii/S1684118223000336
work_keys_str_mv AT chingchulo microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT weiyilei microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT yingchehuang microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT jowjyhhwang microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT chenyulo microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT chienhunglin microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT hsushengcheng microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT yeetamliao microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT pochengliang microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT mengjauchiou microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT mingjongbair microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT chiayendai microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel
AT minglungyu microeliminationofhepatitiscvirusinfectionintheruralandremoteareasoftaiwanamulticentercollaborativecaremodel